24hr Tracked Cold Chain Shipping•Free Shipping on Orders £120+•

Research peptide

CJC-1295 With Dac 5mg

£20.00

In stock

In stock

Earn 20 points when you buy this product
Next dispatch
  --:--:--
Dispatch cut-offs (UK time): Mon–Fri 3pm · Sat 1pm
UK delivery £4.80 · Royal Mail 24hr Tracked
Free delivery on orders over £120.00
Loyalty rewards
Earn 20 points with this product
100 points = £1 off. Join free · How it works
Affiliate programme
Earn 5% commission on every sale you refer

Tracked cold-chain shipping
Same Day Dispatch on orders before 3pm Mon–Fri, 1pm Saturday

3rd-party COAs
Published for every batch

Responsive support
Mon–Fri 9:00–17:00

Secure checkout
Encrypted payment

SKUCD5

For laboratory research use only. Not for human or veterinary use.

Description

CJC-1295 with DAC 5 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.

Research-grade synthetic peptide supplied as a 5 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.

This is not CJC 1295 no DAC / modified GRF(1–29) unless the COA says so. Confirm the DAC-modified sequence on the lot paperwork.

Identification

Product name CJC-1295 with DAC
Also listed as CJC-1295 DAC; Drug Affinity Complex–modified GHRH analogue
Supplier Opti-Gen Peptides
Contents 5 mg per vial
CAS (commonly cited) 863288-34-0
Approx. mass ~3648 Da
Class Synthetic GHRH analogue with albumin-binding moiety
Intended use Laboratory / in-vitro research only

Not sermorelin, tesamorelin or CJC-1295 no DAC.

Quality / storage

Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation or application instructions on this page.

Published research context (not product claims)

CJC-1295 with DAC is a modified GRF(1–29) analogue carrying a Drug Affinity Complex (maleimide linker designed for albumin binding in biochemical models). It was developed in ConjuChem programmes.

Papers such as Teichman et al., JCEM describe clinical-development / pharmacokinetic work on DAC-modified constructs. Those studies concern experimental or development materials. They are not growth-hormone claims for this vial.

CJC-1295 without DAC (modified GRF 1–29) is a shorter analogue and must not be treated as the same listing.

GHRH analogues may be WADA-restricted. There is no UK marketing authorisation for this vial.

UK notice

18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.

Additional information

Weight 0.003 g
Dimensions 1.5 × 1.5 × 4 cm

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 With Dac 5mg”

Your email address will not be published. Required fields are marked *

0